November 20, 2024

Genetic GERD Linked to Cardiovascular, Hypertension Risks

Genetically predicted gastroesophageal reflux disease may significantly increase the risk of myocardial infarction and hypertension.

Conexiant

November 19, 2024

Wide Variation in SGLT2i Use Across U.S. Hospitals

Study reveals hospital variation in SGLT2i prescriptions, with only 11 of 518 hospitals (2.1%) achieving ≥50% prescription rates while 232 hospitals (44.8%) prescribed to fewer than 10% of eligible heart failure patients, highlighting an implementation gap in evidence-based therapy.

Conexiant

November 19, 2024

MASLD Affects 42% of US Adults, Study Finds

A US-based study found Hispanic individuals had significantly higher metabolic dysfunction-associated steatotic liver disease prevalence at 47.0% compared to 40.7% in non-Hispanic whites, despite nearly half of all U.S. adults showing signs of fatty liver disease.

Conexiant

November 19, 2024

Analysis Maps Broad Semaglutide Eligibility

An estimated 136.8 million U.S. adults are eligible for semaglutide, a number exceeding current eligibility for statins, according to an analysis.

Conexiant

November 19, 2024

Kimchi Consumption Reduces Body Fat, Clinical Trial Shows

Trial reveals kimchi's dual action: consuming 3000 mg daily not only reduced body fat mass but also increased beneficial gut bacteria A. muciniphila while decreasing obesity-associated microbes.

Conexiant

November 18, 2024

Diabetes, Amyloid-β Interaction Doubles MCI Risk

Managing diabetes may reduce Alzheimer’s risk, as 20-year data reveal synergistic brain changes from diabetes and amyloid-β abnormality.

Conexiant

November 18, 2024

Skin Disease Signals Hidden Heart Risks

Psoriasis not only marks the skin but also significantly raises the risk of myocardial infarction, stroke, and cardiovascular death, highlighting an urgent need for cardiovascular screening in these patients.

Conexiant

November 18, 2024

Diabetes Drug Cuts Asthma Attacks By 30%

Adding GLP-1 receptor agonists to metformin therapy may reduce asthma attacks.

Conexiant

November 18, 2024

Study Links Coffee Timing to Mortality Risk in Diabetes

A temporal link between coffee timing and mortality reveals that drinking coffee between 5:00-8:00 AM was associated with a 41% higher risk of cardiovascular mortality in patients with diabetes, while consumption between 8:00 AM-noon reduced risk by 21%.

Conexiant